Excelerate Health Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Geno.Me, Inc.May 2025SEC filingmedium confidence
Milwaukee, US
Paul Auer(Director)Brittany Gottschalk(Executive Officer, Director)
BoardMark Bakken(Director)in
Board seatLaura Hilty· per SEC Form D · $650K raise · filed May 2025
Co-investorsHealthX Ventures
OrbitalRxorbitalrx.comin𝕏Oct 2025
OrbitalRX provides a cloud-based platform for hospital pharmacy teams to manage drug shortages through centralized workflows and predictive intelligence.
Enterprise SoftwareHealthtechSaaS
Board seatGary Abrahams· per SEC Form D
Co-investorsAlerion VenturesThe Launch PlaceGood Life Sciences Generations
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.